Diagnosing diseases is basically the frontlines when it comes to fighting against illnesses and how effectively and efficiently this is done will affect how the rest of the battle goes. Unfortunately, diagnosis can be expensive, depending on the disease. Thanks to a new microchip, which can cost only $0.1 to create, this might not be a problem anymore.
The microchip in question was created by a team of engineers from Stanford who published their findings in the Proceedings of the National Academy of Sciences. Not only is the chip tiny, it’s also incredibly inexpensive to produce and can be manufactured at a large scale in a very short period of time.
“For the developing world, point-of-care (POC) diagnostics design must account for limited funds, modest public health infrastructure, and low power availability,” the paper reads. “To address these challenges, here we integrate microfluidics, electronics, and inkjet printing to build an ultra–low-cost, rapid, and miniaturized lab-on-a-chip (LOC) platform.”
Calling it the FNIP chip, the researchers created the device with three layers of varying expendability. As for how it is used, it’s basically a two-step process. First, the user would need to customize the configuration in order to suit the particular disease that needs to be diagnosed, Futurism reports. Next, the necessary samples for analysis can then be printed onto the top layer of the chip.
So, which diseases can this microchip detect? So far, the researchers tested it to analyze cancer fluid and succeeded. They also used it to diagnose immune cells and was able to pull off similar results as another diagnostic tool that would have cost $100,000 in comparison.
Before anyone gets too excited, however, the researchers are saying that it would take some time before the microchip becomes widely available. There are some hurdles to overcome first, including more tests to see if the platform is even safe to use.


California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
South Korea Sees Limited Impact From New U.S. Tariffs on Advanced AI Chips
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 



